{
  "title": "Why Drug Price Negotiation Has Staying Power",
  "link": "https://www.kff.org/health-costs/perspective/why-drug-price-negotiation-has-staying-power/",
  "dc:creator": "",
  "pubDate": "Fri, 25 Jun 2021 09:00:25 +0000",
  "category": [
    "Health Costs",
    "Health Reform",
    "Medicare",
    "Prescription Drugs"
  ],
  "guid": "https://www.kff.org/?post_type=perspective&#038;p=526561",
  "description": "In this Axios column, Drew Altman looks beyond Medicare to whatâ€™s at stake for employers and workers in the debate about the government negotiating drug prices.",
  "post-id": 526561,
  "media:content": {
    "media:title": "drew_drugs",
    "media:description": "",
    "media:thumbnail": ""
  }
}